Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Hematologic Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Obesity 1Neoplasm, Residual 1Myelodysplastic Syndromes 1Multiple Myeloma 1Motor Activity 1Melanoma 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia, Hairy Cell 1Leukemia 1Hodgkin Disease 1FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1Colorectal Neoplasms 1Cardiotoxicity 1Carcinoma, Merkel Cell 1Breast Neoplasms 1

Interventions

Exercise 4Tirzepatide 2semaglutide 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1Ursodeoxycholic Acid 1Urine Specimen Collection 1Topiramate 1Surveys and Questionnaires 1Standard of Care 1Specimen Handling 1Resistance Training 1Qsymia 1Phentermine 1Naltrexone 1Liraglutide 1Glucagon-Like Peptide-1 Receptor 1Fluorescence Polarization Immunoassay 1Exercise Test 1Echocardiography 1Docosahexaenoic Acids 1Diethylpropion 1Diet, Plant-Based 1Diet 1Counseling 1Caloric Restriction 1Bupropion 1Blood Specimen Collection 1Biopsy 1Adiposity 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Obesity × Exercise Test × Clear all
NCT02774759 2026-03-09

Feasibility of the NEXT Steps Weight Loss Intervention +/- Resistance Training for Endometrial Cancer Survivors: Effect on Lean Mass & Biomarkers

M.D. Anderson Cancer Center

Phase NA Active not recruiting
15 enrolled
Other

Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡